Poncirus trifoliate is a traditional Chinese medicinal plant used for treating
inflammation-related diseases for a long time and trifoliate orange contains abundant
auraptene. The present study was to evaluate
auraptene as a potential
anti-inflammatory agent and investigate the mechanism of
auraptene against
prostaglandins E2 (
PGE2) and
cyclooxygenase-2 (COX-2) on
lipopolysaccharide (LPS)-stimulated RAW 264.7 cells by comparing it with
aspirin as a positive control group. The methods of
enzyme-linked
immunosorbent assay, reverse transcriptive polymerase chain reaction, real-time PCR, and western-blotting were used in the study. The results showed that
auraptene exhibited better biocompatibility and lower cytotoxicity. At the same time, it significantly inhibited the production of
PGE2 on LPS-stimulated macrophage cells. The
auraptene-treated group had a higher COX-2
mRNA expression but relatively lower COX-2
protein level which implied that
auraptene suppressed the post-transcriptional expression of COX-2
protein but not the transcriptional process. Compared with
aspirin, the lower cytotoxicity of
auraptene can make it a potential source for medicine that can benefit patients who are suffering from chronic inflammatory diseases and need long-term medication.